Knights Of Columbus Asset Advisors LLC Denali Therapeutics Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.59 Billion
- Q2 2025
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 38,479 shares of DNLI stock, worth $552,173. This represents 0.03% of its overall portfolio holdings.
Number of Shares
38,479
Previous 40,275
4.46%
Holding current value
$552,173
Previous $547,000
1.65%
% of portfolio
0.03%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding DNLI
# of Institutions
237Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$189 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$172 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$169 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$164 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$97.1 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.93B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...